Jump to content

Choose locationNot Set
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location

We've expanded your view

You are now viewing all services in the Sutter Health network. You can change your location above to narrow your view to a medical group, hospital, city or zip.
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
  • Locations
  • Sign in or Enroll
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Diseases & Conditions
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Ways to Give
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Research
  • Prostate Cancer
Content

Adjuvant (AFT-19)

Description

A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Contact Person: Tanya Pozniansky

Please contact l: pozniat@sutterhealth.org about Adjuvant AFT-19

Location: PAMF (Peninsula/South Bay)

View study details on ClinicalTrials.gov

Principal Investigator

Bryant C. Sheh, M.D.

Co-Investigator(s)

M. Dwight Chen, M.D., David S. Leibowitz, M.D., FACP, Glenn D. Wong, D.O., Kim-Son Nguyen, M.D., Paula D. Kushlan, M.D., Priya Chakravarthi, M.D., Gillian L. Hsieh, M.D., Natalia Colocci, M.D., Ph.D., Monique de Bruin, M.D., MPH, Albert Pisani, M.D., Derrick Wong, M.D., Edmund W. Tai, M.D., Huan T. Ha, M.D., Michael C. Wu, M.D., Irene Wu, M.D., Janet Wang, M.D. 

Recruitment Status

Active, Recruiting

Start Date

February 01, 2019

Related Studies

Genomic Health Oncotype DX AR-V7

Genomic Health 09-060: A real-world observational study to provide prospective information on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) with disease progression after at least one line of androgen receptor-targeted therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent management

Investigators: Rajeswari Chellappah, M.D., Brian K. Kim, M.D, Nitin Rohatgi, MD, Sivakumar Reddy, M.D., David Yee, M.D., MPH, Kristin N. Arreola, M.D. 

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

About Sutter

  • About Our Network
  • Annual Report
  • Awards
  • Community Benefit
  • Contact Us
  • News Room
  • Ways to Give

    • Find Care

  • Birth Centers
  • Care Centers
  • Emergency Rooms
  • Hospitals
  • Imaging
  • Labs
  • Surgery Centers
  • Urgent Care
  • Walk-In Care
  • View All >

    • Featured Services

  • Behavioral Health
  • Cancer Services
  • Family Medicine
  • Home Health and Hospice
  • Orthopedics
  • Pediatrics
  • Pregnancy
  • Primary Care
  • Women's Health
  • View All >

    • Patient Resources

  • Accepted Health Plans
  • Classes and Events
  • Estimate Costs
  • Flu Resources
  • Health and Wellness
  • Medical Records
  • Medicare
  • My Health Online
  • Pay a Bill
  • Symptom Checker

    • Our Team

  • For Employees
  • Physician Careers
  • Recruiting Events
  • Sutter Careers
  • Vendors
  • Volunteers
    • ADA Accessibility
    • Contact
    • Privacy
    • Do Not Sell My Info

    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Glassdoor Opens new window
    • Instagram Opens new window

    Copyright © 2020 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

    Cookie Policy

    We use cookies to give you the best possible user experience. By clicking on "Accept Cookies", closing this pop-up banner or by continuing to use the site, you agree to the use of cookies. Privacy Policy   Cookie Preferences